81318 Pms2 known familial variants
Also known as: PMS2 familial variant testing, Lynch syndrome family screening
Post-Meiotic Segregation Increased 2 (PMS2) gene analysis for known familial variants to facilitate family member screening.
In Plain Language
Family Lynch syndrome test; Inherited cancer genetic testing
Clinical Context
Targeted PMS2 testing of family members for previously identified variants in Lynch syndrome families.
RVU Information
CPT 81318 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81318?
CPT 81318 (Pms2 known familial variants) is a Pathology & Lab code. Post-Meiotic Segregation Increased 2 (PMS2) gene analysis for known familial variants to facilitate family member screening.
Who uses CPT code 81318?
CPT 81318 is used by Pathology, Oncology, Gastroenterology. Targeted PMS2 testing of family members for previously identified variants in Lynch syndrome families.
When is CPT 81318 used?
Targeted PMS2 testing of family members for previously identified variants in Lynch syndrome families.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.